x

Search for a clinical trial

* (*) mandatory field

Other search option(s)

2 Result(s)

Recruiting trial = Recruiting trial ; Ongoing trial = Ongoing trial ; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial Non-Randomized, Open Label Phase II Safety/Efficacy Study: Replace Sandostatine® in Three Daily Subcutaneous Injections by a Single Intramuscular Injection of Sandostatine® LP Per Month in Patients With a Diffuse Form of Hyperinsulinism
Hôpital Necker-Enfants Malades
Service des Maladies Métaboliques pédiatriques

More details
FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial Funded by an IRDiRC memberSONIA 2: An international, multicenter, randomized, evaluator-blinded, no-treatment controlled, parallel-group study to assess the efficacy and safety of once daily nitisinone in patients with alkaptonuria after 12 months of treatment, followed by an additional 36-month treatment period (phase III) - FR
Hôpital Necker-Enfants Malades
Service des Maladies Métaboliques pédiatriques

More details